KINETIC INTERACTIONS BETWEEN AZLOCILLIN, CEFOTAXIME, AND CEFOTAXIME METABOLITES IN NORMAL AND IMPAIRED RENAL-FUNCTION

被引：16

作者：

KAMPF, D ^{[1
]}

BORNER, K ^{[1
]}

MOLLER, M ^{[1
]}

KESSEL, M ^{[1
]}

机构：

[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,INST KLIN CHEM & KLIN BIOCHEM,D-1000 BERLIN 45,FED REP GER

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 02期

关键词：

D O I：

10.1038/clpt.1984.29

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：214 / 220

页数：7

共 37 条

[1]

ARVIDSSON A, 1979, CLIN PHARMACOL THER, V25, P870

[2]

BARNES RC, 1982, 22ND INT C ANT AG CH, P66

[3]

BAX R, 1980, CURRENT CHEMOTHERAPY, V1, P155

[4]

Bergan T, 1978, Antibiot Chemother (1971), V25, P1

[5]

BORNER K, 1980, J CLIN CHEM CLIN BIO, V18, P719

[6]

BRAVENY I, 1981, KOMBINATIONEN BETALA, P3

[7]

BRAVENY I, 1982, KLINISCHE BEWERTUNG, P73

[8]

BUBRICK MP, 1982, 22ND INT C ANT AG CH, P165

[9]

CASTANER J, 1978, Drugs of the Future, V3, P749

[10] METABOLISM OF CEFOTAXIME IN ANIMALS AND MAN [J].

CHAMBERLAIN, J ;

COOMBES, JD ;

DELL, D ;

FROMSON, JM ;

INGS, RJ ;

MACDONALD, CM ;

MCEWEN, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 :69-78

← 1 2 3 4 →